Scarica l'app Stockscreener
69.43
2.72%
-1.94
Pre-mercato:
69.46
0.03
+0.04%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMDX Giù?
Forum
Previsione
Precedente Chiudi:
$71.37
Aprire:
$71.99
Volume 24 ore:
1.04M
Relative Volume:
0.82
Capitalizzazione di mercato:
$2.40B
Reddito:
$605.49M
Utile/perdita netta:
$190.29M
Rapporto P/E:
14.29
EPS:
4.8571
Flusso di cassa netto:
$133.59M
1 W Prestazione:
+3.32%
1M Prestazione:
-26.86%
6M Prestazione:
-49.14%
1 anno Prestazione:
-48.79%
Intervallo 1D:
$68.94
$73.50
Intervallo di 1 settimana:
$64.90
$73.91
Portata 52W:
$60.10
$156.00
Transmedics Group Inc Stock (TMDX) Company Profile
Nome
Transmedics Group Inc
Settore
Industria
Telefono
(978) 552-0900
Indirizzo
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
69.43 | 2.47B | 605.49M | 190.29M | 133.59M | 4.8571 |
ABT
Abbott Laboratories
|
91.07 | 158.12B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.66 | 115.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
81.67 | 105.19B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
48.55 | 72.61B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.96 | 50.35B | 6.30B | 1.07B | 1.09B | 1.8406 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-23 | Aggiornamento | Needham | Hold → Buy |
| 2025-10-13 | Iniziato | Jefferies | Buy |
| 2025-09-16 | Iniziato | Evercore ISI | Outperform |
| 2025-09-04 | Iniziato | Stifel | Hold |
| 2024-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-11-22 | Downgrade | Needham | Buy → Hold |
| 2024-10-29 | Reiterato | Needham | Buy |
| 2024-10-29 | Reiterato | Oppenheimer | Outperform |
| 2024-09-24 | Iniziato | Robert W. Baird | Outperform |
| 2024-08-21 | Iniziato | Needham | Buy |
| 2024-06-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-06-04 | Iniziato | Stephens | Overweight |
| 2024-03-28 | Iniziato | Piper Sandler | Overweight |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2022-08-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-10-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-04-07 | Iniziato | Oppenheimer | Outperform |
| 2019-05-28 | Iniziato | Canaccord Genuity | Buy |
| 2019-05-28 | Iniziato | Cowen | Outperform |
| 2019-05-28 | Iniziato | JP Morgan | Overweight |
| 2019-05-28 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Transmedics Group Inc Borsa (TMDX) Ultime notizie
TransMedics Group, Inc. Trade Ideas — XETR:8T8 - TradingView
Price to book ratio of TransMedics Group, Inc. – XETR:8T8 - TradingView
Will Analyst Focus on TransMedics’ OCS Platform and Financial Metrics Change TransMedics Group’s (TMDX) Narrative? - Yahoo Finance
TransMedics faces earnings test as jet fuel costs weigh By Investing.com - Investing.com Australia
TransMedics Group Inc Stock Operating Data - GuruFocus
Oppenheimer downgrades TransMedics stock rating on sentiment concerns - Investing.com
3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market - AOL.com
3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market - The Motley Fool
TransMedics Group Inc (NASDAQ:TMDX): An Affordable Growth Play With Strong Fundamentals - ChartMill
Earnings call transcript: TransMedics Q1 2026 misses EPS forecast, stock stable - Investing.com Australia
TransMedics Group, Inc. (TMDX) Presents at 46th Annual William Blair Growth Stock ConferenceSlideshow - Seeking Alpha
TransMedics (TMDX) Down 4.4% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Oppenheimer downgrades TransMedics stock rating on sentiment concerns By Investing.com - Investing.com UK
TMDX: Revolutionizing organ transplantation with record utilization rates and ambitious global growth targets - TradingView
TransMedics Group, Inc. (NASDAQ:TMDX) Given Average Rating of "Hold" by Brokerages - MarketBeat
TransMedics Group, Inc. (TMDX) Stock Analysis: A 73.78% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
This Healthcare Infrastructure Stock Is Risky, But the Upside Looks Huge - The Globe and Mail
Reasons to retain TransMedics stock in your portfolio for now - MSN
What Drove TransMedics' Stellar Q4 2025 Performance - Kavout
Is TransMedics Group Inc (TMDX) a Bargain After 3.3% Drop? GF Va - GuruFocus
Reasons to Retain TransMedics Stock in Your Portfolio for Now - Yahoo Finance
Retail Traders Swarm TransMedics After Q3 Print— Retail Bulls Call It A ‘Hardcore Dip Buy’ - MSN
Avoiding Lag: Real-Time Signals in (TMDX) Movement - Stock Traders Daily
TMDX Maintained by Stifel -- Price Target Lowered to $75.00 - GuruFocus
TransMedics Group Inc (TMDX) Stock Price, Trades & News - GuruFocus
Stifel Nicolaus Lowers TransMedics Group (NASDAQ:TMDX) Price Target to $75.00 - MarketBeat
Stifel cuts TransMedics stock price target on heart market weakness - Investing.com
Stifel cuts TransMedics stock price target on heart market weakness By Investing.com - Investing.com India
TransMedics: Despite Earnings Miss, Growth Story Remains Intact (NASDAQ:TMDX) - Seeking Alpha
TransMedics Group, Inc. (TMDX) Stock Analysis: Unveiling a 71% Potential Upside in the Medical Device Sector - DirectorsTalk Interviews
TransMedics Group Inc Stock Warning Signs | MIL:1TMDX - GuruFocus
TMDX SEC FilingsTransmedics Group 10-K, 10-Q, 8-K Forms - Stock Titan
TransMedics Group Inc (TMDX) Stock Price, Quote, News & History - Benzinga
TransMedics (TMDX) director receives 2,922 RSU award, holds 5,788 shares - Stock Titan
Director at TransMedics (TMDX) receives 2,922 RSUs, lifting holdings to 15,056 shares - Stock Titan
TransMedics (TMDX) director Merilee Raines receives 2,922 RSU award - Stock Titan
TransMedics (TMDX) director receives 2,922 RSUs in equity grant - Stock Titan
Director at TransMedics (TMDX) receives 2,922 RSU equity grant, holds 5,788 shares - Stock Titan
[Form 4] TransMedics Group, Inc. Insider Trading Activity - Stock Titan
TransMedics (TMDX) director Edwin Kania awarded 2,922 RSUs, now holds over 300K shares - Stock Titan
TransMedics (TMDX) officer receives RSU and stock option grants tied to service - Stock Titan
TransMedics (NASDAQ: TMDX) investors approve directors, pay, stock plan and auditor - Stock Titan
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - marketscreener.com
Organ-transplant firm TransMedics hands new hires stock and RSUs - Stock Titan
TransMedics Group stock (US89366D3075): organ transplant tech in focus after conference appearance - AD HOC NEWS
Transmedics Group Inc Annual Shareholders Meeting Transcript - GuruFocus
TransMedics Group Inc (TMDX) Shares Fall 3.2% -- What GF Score o - GuruFocus
TransMedics to Present at the William Blair 46th Annual Growth Stock Conference - 富途牛牛
TransMedics Group Inc (TMDX) Shares Fall 3.2% -- What GF Score of 75 Tells Investors - GuruFocus
TransMedics Group, Inc. to Present at William Blair 46th Annual Growth Stock Conference on May 19, 2026 - geneonline.com
TransMedics Group, Inc.Common Stock (NQ: TMDX - FinancialContent
Transmedics Group Inc Azioni (TMDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Transmedics Group Inc Azioni (TMDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Weill David | Director |
Mar 04 '26 |
Option Exercise |
14.20 |
3,571 |
50,708 |
15,705 |
| Weill David | Director |
Mar 04 '26 |
Sale |
146.82 |
3,571 |
524,294 |
12,134 |
| Hernandez Gerardo | Chief Financial Officer |
Mar 04 '26 |
Option Exercise |
71.17 |
7,236 |
515,001 |
20,601 |
| Hernandez Gerardo | Chief Financial Officer |
Mar 04 '26 |
Sale |
147.21 |
7,236 |
1,065,212 |
14,689 |
| Hernandez Gerardo | Chief Financial Officer |
Mar 02 '26 |
Sale |
139.12 |
375 |
52,170 |
14,689 |
| Ranganath Anil P. | See remarks |
Mar 02 '26 |
Sale |
139.12 |
864 |
120,200 |
13,091 |
| Corcoran Nicholas | See remarks |
Mar 02 '26 |
Sale |
139.12 |
2,966 |
412,630 |
29,831 |
0.74%
1.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):